Clinical and biological characteristics of rheumatoid arthritis (RA) patients treated with adalimumab, etanercept or abatacept. (DOC 61 kb
Table S1. Univariate logistic regression analysis for associated factors to predict ACR20 response a...
Baseline characteristics of each latent class (including data from Table 4). (DOCX 18 kb
DAS28–4(CRP) of less than 2.6 and ACR/EULAR remission by study visit (ITT population). Abbreviations...
Modulation of RasGRP3 gene expression levels in peripheral blood mononuclear cells (PBMCs) from heal...
TNF receptor (TNFR)1 and TNFR2 have no effect on RasGRP1 and RasGRP3 gene expression level in T and ...
T and B cell purity. After negative selection of peripheral blood mononuclear cells from healthy con...
Incidence rates (95 % CI) of severe adverse events among RA patients; subgroup analysis for more eld...
A model of RasGRP1 regulation by TNFα. In T cells, TNFα binding to TNF receptor-1 (TNFR1) leads to a...
Table S1. Association of gene expression profiles with vascular pathophysiology in biologic-naïve RA...
The levels of ACPA, HMGB1, S100A8/A9 in individual RASF samples from 40 patients with RA (Pat) and t...
Disease activity at baseline in the rituximab database (IMAGE trial of early rheumatoid arthritis). ...
Patients’ characteristics (immunohistochemistry studies on needle arthroscopic biopsies). Characteri...
Rates of adverse events (trimmed population) in patients receiving rituximab or anti-TNF agents. (DO...
The levels of ACPA, HMGB1 and S100A8/A9 in individual RASF samples pooled to create a single sample ...
Table S1. Matrix of ICC scores of three readers who contributed to the data; each MRI was evaluated ...
Table S1. Univariate logistic regression analysis for associated factors to predict ACR20 response a...
Baseline characteristics of each latent class (including data from Table 4). (DOCX 18 kb
DAS28–4(CRP) of less than 2.6 and ACR/EULAR remission by study visit (ITT population). Abbreviations...
Modulation of RasGRP3 gene expression levels in peripheral blood mononuclear cells (PBMCs) from heal...
TNF receptor (TNFR)1 and TNFR2 have no effect on RasGRP1 and RasGRP3 gene expression level in T and ...
T and B cell purity. After negative selection of peripheral blood mononuclear cells from healthy con...
Incidence rates (95 % CI) of severe adverse events among RA patients; subgroup analysis for more eld...
A model of RasGRP1 regulation by TNFα. In T cells, TNFα binding to TNF receptor-1 (TNFR1) leads to a...
Table S1. Association of gene expression profiles with vascular pathophysiology in biologic-naïve RA...
The levels of ACPA, HMGB1, S100A8/A9 in individual RASF samples from 40 patients with RA (Pat) and t...
Disease activity at baseline in the rituximab database (IMAGE trial of early rheumatoid arthritis). ...
Patients’ characteristics (immunohistochemistry studies on needle arthroscopic biopsies). Characteri...
Rates of adverse events (trimmed population) in patients receiving rituximab or anti-TNF agents. (DO...
The levels of ACPA, HMGB1 and S100A8/A9 in individual RASF samples pooled to create a single sample ...
Table S1. Matrix of ICC scores of three readers who contributed to the data; each MRI was evaluated ...
Table S1. Univariate logistic regression analysis for associated factors to predict ACR20 response a...
Baseline characteristics of each latent class (including data from Table 4). (DOCX 18 kb
DAS28–4(CRP) of less than 2.6 and ACR/EULAR remission by study visit (ITT population). Abbreviations...